These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 378036)

  • 21. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aspirin as a platelet antiaggregant: indications and controversies].
    Stalder M; Bachmann F
    Ther Umsch; 1987 Aug; 44(8):584-90. PubMed ID: 3313789
    [No Abstract]   [Full Text] [Related]  

  • 23. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study.
    Andrassy K; Malluche H; Bornefeld H; Comberg M; Ritz E; Jesdinsky H; Möhring K
    Klin Wochenschr; 1974 Apr; 52(7):348-9. PubMed ID: 4600820
    [No Abstract]   [Full Text] [Related]  

  • 25. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial.
    Hess H; Mietaschk A; Deichsel G
    Lancet; 1985 Feb; 1(8426):415-9. PubMed ID: 2857803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of stroke.
    Barnett HJ
    Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of the combination of aspirin and nifedipine on platelet aggregation and thrombogenesis].
    Dong E; Shi S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):301-3, 319. PubMed ID: 2086198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5-year controlled therapy study on the prevention of diabetic angiopathy with the platelet-function inhibitor acetylsalicylic acid].
    Zabel-Langhennig R; Ruttmann B; Schiele I; Schäfer W; Aisch W
    Z Gesamte Inn Med; 1982 Oct; 37(19):661-5. PubMed ID: 7180065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
    Ehresmann U; Alemany J; Loew D
    Med Welt; 1977 Jul; 28(26):1157-62. PubMed ID: 886967
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Drug therapy for prevention of arterial thrombosis.
    Sixma JJ
    Neth J Med; 1975; 18(4):121-4. PubMed ID: 1165829
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection by aspirin against experimentally induced arterial thrombosis in dogs.
    Danese CA; Voleti CD; Weiss HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(2):288-96. PubMed ID: 5568048
    [No Abstract]   [Full Text] [Related]  

  • 34. [The action of various drugs in the prevention of re-occlusion following Dotter's catheter disobliteration].
    Zeitler E
    Med Welt; 1976 Jul; 27(28):1377-80. PubMed ID: 785147
    [No Abstract]   [Full Text] [Related]  

  • 35. The biologic background to some therapeutic uses of aspirin.
    Born GV; Görög P; Begent NA
    Am J Med; 1983 Jun; 74(6A):2-9. PubMed ID: 6344623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
    Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN
    Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin inhibition of platelet deposition at angioplasty sites: demonstration by platelet scintigraphy.
    Cunningham DA; Kumar B; Siegel BA; Gilula LA; Totty WG; Welch MJ
    Radiology; 1984 May; 151(2):487-90. PubMed ID: 6231656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
    Loew D
    Med Welt; 1979 Feb; 30(5):166-9. PubMed ID: 759804
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.